Who Owns Medpace Stock?
NASDAQ: MEDPHealthcareDiagnostics & ResearchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 91.38%
- Institutions (% of float)
- 112.45%
- Held by insiders
- 18.74%
- Institutional holders
- 924
- Institutions 81.3%
- Insiders 18.7%
- Public and other 0.0%
Who owns Medpace stock?
Institutional investors own about 91.4% of Medpace's shares, spread across 924 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 18.74% of MEDP.
The largest institutional holders are Blackrock Inc. (8.95%), Price (T.Rowe) Associates Inc (7.42%) and AQR Capital Management, LLC (4.58%). Together, the top 10 institutions control 39.8% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MEDP positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MEDP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 2.50M | 8.95% | +1.1% |
| Price (T.Rowe) Associates Inc | 2.07M | 7.42% | +614.9% |
| AQR Capital Management, LLC | 1.28M | 4.58% | -5.5% |
| Vanguard Portfolio Management LLC | 1.13M | 4.06% | +1.0% |
| Vanguard Capital Management LLC | 1.03M | 3.68% | +1.6% |
| State Street Corporation | 710.89K | 2.55% | +4.2% |
| Geode Capital Management, LLC | 710.47K | 2.55% | -4.7% |
| Wasatch Advisors LP | 636.60K | 2.28% | -17.8% |
| Invesco Ltd. | 579.24K | 2.08% | +0.3% |
| BAILLIE GIFFORD & CO | 473.21K | 1.70% | -6.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MEDP
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 790.32K | 2.83% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 724.94K | 2.60% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 523.66K | 1.88% |
| T. Rowe Price Equity Funds, Inc.-T. Rowe Price Large-Cap Growth Fund | 376.36K | 1.35% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 302.06K | 1.08% |
| Invesco Exchange-Traded Fund Trust-Invesco S&P MidCap Quality ETF | 296.07K | 1.06% |
| Vanguard Explorer Fund | 269.62K | 0.97% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 258.77K | 0.93% |
| TR PRICE-Price (T.Rowe) Large Cap Growth Trust | 239.20K | 0.86% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 173.05K | 0.62% |
Frequently asked questions
Who is the largest shareholder of Medpace?
Blackrock Inc. is the largest institutional shareholder of MEDP, owning 8.95% of shares outstanding (2.50M shares) as of its latest 13F filing.
What percentage of Medpace is owned by institutions?
Institutions own about 91.4% of MEDP shares and 112.5% of the public float.
How much of Medpace do insiders own?
Insiders, such as officers and directors, own about 18.74% of MEDP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.